ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • Vis innførsel
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Serum lactate dehydrogenase contributes to prognostic assessment in patients with oligometastatic cancer and brain involvement

Permanent lenke
https://hdl.handle.net/10037/18684
DOI
https://doi.org/10.21873/invivo.11464
Thumbnail
Åpne
article.pdf (93.94Kb)
Publisert versjon (PDF)
Dato
2019-01
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Nieder, Carsten; Dalhaug, Astrid; Pawinski, Adam
Sammendrag

Background/Aim - The aim of this study was to analyze the prognostic impact of serum lactate dehydrogenase (LDH) in patients with oligometastatic brain metastases, arbitrarily defined as max. Four brain lesions and 5 metastatic lesions overall.

Patients and Methods - This was a retrospective single institution analysis. Overall, 42 patients were identified from a prospectively maintained database.

Results - Seventeen patients (40%) had extracranial metastases. Twelve patients (29%) had elevated LDH (≥255 U/l). Their median survival was significantly shorter than that of patients with normal LDH. Due to an interaction with performance status, this result was separately confirmed in patients with performance status ≥70.

Conclusion - Oligometastatic disease is not always correctly diagnosed, because all radiological modalities are limited by certain thresholds for detection of small metastases. We hypothesize that LDH is associated with survival, because this biomarker may reflect the total burden of malignant disease. Future studies should examine whether or not ablative local treatment of oligometastases is warranted in patients with elevated LDH.

Forlag
International Institute of Anticancer Research
Sitering
Nieder C, Dalhaug A, Pawinski A. Serum lactate dehydrogenase contributes to prognostic assessment in patients with oligometastatic cancer and brain involvement. In Vivo. 2019;33(1):229-232
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (klinisk medisin) [1974]
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring